We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$37.8B
AUM Growth
+$3.94B
Cap. Flow
+$1.54B
Cap. Flow %
4.08%
Top 10 Hldgs %
22%
Holding
1,437
New
65
Increased
570
Reduced
395
Closed
99

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$73.7M
2
LIN icon
Linde
LIN
+$68.9M
3
SHW icon
Sherwin-Williams
SHW
+$52.4M
4
MDT icon
Medtronic
MDT
+$52.2M
5
CRM icon
Salesforce
CRM
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.8%
2 Healthcare 19.83%
3 Financials 11.79%
4 Industrials 9.64%
5 Consumer Staples 8.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPH icon
1051
Amphastar Pharmaceuticals
AMPH
$869M
$470K ﹤0.01%
16,800
UMBF icon
1052
UMB Financial
UMBF
$11.2B
$470K ﹤0.01%
5,648
LCID icon
1053
Lucid Motors
LCID
$2.64B
$469K ﹤0.01%
7,062
+889
+14% +$97.8K
TXNM
1054
TXNM Energy Inc
TXNM
$5.91B
$466K ﹤0.01%
+9,532
New +$454K
RXRX icon
1055
Recursion Pharmaceuticals
RXRX
$1.8B
$460K ﹤0.01%
60,000
NXST icon
1056
Nexstar Media Group
NXST
$5.69B
$456K ﹤0.01%
2,601
-2,403
-48% -$422K
GMED icon
1057
Globus Medical
GMED
$11.4B
$448K ﹤0.01%
6,036
-480
-7% -$32.7K
NWL icon
1058
Newell Brands
NWL
$2.62B
$448K ﹤0.01%
34,368
-20,718
-38% -$283K
TDC icon
1059
Teradata
TDC
$2.5B
$447K ﹤0.01%
13,474
-1,084
-7% -$34.9K
QTWO icon
1060
Q2 Holdings
QTWO
$3.95B
$446K ﹤0.01%
17,000
RLAY icon
1061
Relay Therapeutics
RLAY
$4.38B
$445K ﹤0.01%
30,100
MAXR
1062
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$445K ﹤0.01%
8,613
+2,639
+44% +$72.4K
ADPT icon
1063
Adaptive Biotechnologies
ADPT
$4.04B
$444K ﹤0.01%
59,600
ATR icon
1064
AptarGroup
ATR
$8.57B
$442K ﹤0.01%
4,022
GGG icon
1065
Graco
GGG
$13.5B
$441K ﹤0.01%
6,566
ARQT icon
1066
Arcutis Biotherapeutics
ARQT
$3.3B
$438K ﹤0.01%
30,000
ICL icon
1067
ICL Group
ICL
$6.89B
$433K ﹤0.01%
59,956
+5,851
+11% +$48.5K
VERV
1068
DELISTED
Verve Therapeutics
VERV
$433K ﹤0.01%
23,000
SRCL
1069
DELISTED
Stericycle Inc
SRCL
$433K ﹤0.01%
8,700
JBGS
1070
JBG SMITH
JBGS
$664M
$431K ﹤0.01%
23,204
CHWY icon
1071
Chewy
CHWY
$9.2B
$429K ﹤0.01%
11,620
-201
-2% -$7.83K
SANA icon
1072
Sana Biotechnology
SANA
$1.05B
$426K ﹤0.01%
112,300
SWTX
1073
DELISTED
SpringWorks Therapeutics
SWTX
$421K ﹤0.01%
17,250
EXE
1074
Expand Energy Corp
EXE
$22.7B
$417K ﹤0.01%
+4,464
New +$442K
SIGA icon
1075
SIGA Technologies
SIGA
$207M
$416K ﹤0.01%
57,254
+27,254
+91% +$239K

Similar funds

DekaBank Deutsche Girozentrale's Q4 2022 Portfolio in Review

As of Q4 2022, DekaBank Deutsche Girozentrale held 1,437 positions worth $37.8B, up 12% from $33.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

DekaBank Deutsche Girozentrale deployed $1.54B of net new capital in Q4 2022, opening 65 new positions and adding to 570 existing holdings. Its largest new stake was Wolfspeed: 120,839 shares worth $8.28M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $73.7M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2022 buy was Wolfspeed: 120,839 shares worth $8.28M.
  • DekaBank Deutsche Girozentrale added most to Alphabet (Google) Class A in Q4 2022, an estimated $186M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $73.7M.
  • DekaBank Deutsche Girozentrale fully exited Duke Realty Corp. in Q4 2022, selling an estimated $16.3M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 22% of its $37.8B portfolio in Q4 2022.
  • DekaBank Deutsche Girozentrale opened 65 new positions and closed 99 in Q4 2022.
  • DekaBank Deutsche Girozentrale's portfolio value rose 12% quarter-over-quarter to $37.8B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2022, filed 1 Feb 2023.